Literature DB >> 7874837

Serum vitamin A and E concentrations in acute falciparum malaria: modulators or markers of severity?

T M Davis1, T Q Binh, P T Danh, J R Dyer, A St John, P Garcia-Webb, T K Anh.   

Abstract

1. To assess the association between vitamin A, vitamin E and the clinical course of severe malaria, serial morning blood samples were taken from 24 Vietnamese patients, aged 18-62 years, receiving intensive treatment for complicated Plasmodium falciparum infections. A single fasting blood sample was also taken from 10 control subjects aged 22-45 years. Serum retinol, carotene and vitamin E concentrations were measured by h.p.l.c. 2. Admission serum retinol concentration was depressed relative to that of the control subjects (0.69 +/- 0.35 versus 1.86 +/- 0.41 mumol/l mean +/- SD, P < 0.001) and correlated inversely with indices of hepatic function, but positively with the simultaneous serum creatinine concentration (P < 0.05). During the first week of treatment, serum retinol concentration increased in parallel with improving liver function, whereas serum creatinine concentration remained elevated in the majority of patients. Serum alpha- and beta-carotene concentrations remained depressed throughout. 3. Serum vitamin E concentration, corrected for total serum cholesterol concentration in the form of a ratio, was also depressed at presentation (3.1 +/- 1.8 x 10(3) versus 4.2 +/- 0.8 x 10(3) in control subjects; P < 0.05), but tended to be higher than the control value at the time of discharge (0.1 > P > 0.05); there was a significant correlation between admission ratio and parasite clearance time (P = 0.04). 4. On the basis of this and previous studies, vitamin A replacement could be considered in selected severely ill patients without renal impairment. As found previously in animal models, depressed vitamin E levels may have a beneficial effect on the course of malarial infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7874837     DOI: 10.1042/cs0870505

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

Review 1.  The role of antioxidants treatment on the pathogenesis of malarial infections: a review.

Authors:  Murtala Bindawa Isah; Mohammed Auwal Ibrahim
Journal:  Parasitol Res       Date:  2014-02-13       Impact factor: 2.289

2.  Studies on biochemical changes with special reference to oxidant and antioxidants in malaria patients.

Authors:  A G Kulkarni; A N Suryakar; A S Sardeshmukh; D B Rathi
Journal:  Indian J Clin Biochem       Date:  2003-07

3.  Comparative study on lipid peroxidation and antioxidant vitamins E and C inFalciparum andVivax malaria.

Authors:  Vivian D'Souza; Benedicta D'Souza
Journal:  Indian J Clin Biochem       Date:  2006-09

4.  Pharmacodynamic interaction between mefloquine and retinol in Plasmodium falciparum in vitro.

Authors:  Maria Gruber; Gunther Wernsdorfer; Wichai Satimai; Ursula Wiedermann; Kanungnit Congpuong; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2009-10       Impact factor: 1.704

5.  Micronutrient Deficiencies and Plasmodium vivax Malaria among Children in the Brazilian Amazon.

Authors:  Silvana Gomes Benzecry; Márcia Almeida Alexandre; Sheila Vítor-Silva; Jorge Luis Salinas; Gisely Cardoso de Melo; Helyde Albuquerque Marinho; Ângela Tavares Paes; André Machado de Siqueira; Wuelton Marcelo Monteiro; Marcus Vinícius Guimarães Lacerda; Heitor Pons Leite
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

Review 6.  Malaria and vitamin A deficiency in African children: a vicious circle?

Authors:  Miguel A Sanjoaquin; Malcolm E Molyneux
Journal:  Malar J       Date:  2009-06-17       Impact factor: 2.979

7.  Synergistic interaction between atovaquone and retinol in Plasmodium falciparum in vitro.

Authors:  Bettina Exner; Gunther Wernsdorfer; Jeeraphat Sirichaisinthop; Chaiporn Rojanawatsirivet; Herwig Kollaritsch; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 2.275

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.